INT55340

From wiki-pain
(Difference between revisions)
Jump to: navigation, search
(Generated page)
(Generated page)
 
Line 31: Line 31:
 
|-
 
|-
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"| Disease Relevance
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"| Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;" align="center"| 8.5412
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;" align="center"| 8.54
 
|-
 
|-
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"| Pain Relevance
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"| Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;" align="center"| 4.8712
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;" align="center"| 4.87
 
|-
 
|-
 
|}
 
|}
Line 107: Line 107:
 
|}
 
|}
 
{| cellspacing=2 cellpadding=2
 
{| cellspacing=2 cellpadding=2
|
+
| style="vertical-align: top"|
 
{| cellspacing=1 cellpadding=5 align=center
 
{| cellspacing=1 cellpadding=5 align=center
 
|-
 
|-
Line 117: Line 117:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Angina]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Angina]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 51
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 51
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 100
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 100.00
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
|-
 
|-
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[anesthesia]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[anesthesia]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 6
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 6
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 95
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 95.00
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|High}} {{#icon: chilli.png|High}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|High}} {{#icon: chilli.png|High}}
 
|-
 
|-
Line 132: Line 132:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[imagery]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[imagery]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 2
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 2
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 50
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 50.00
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: cold.png|Quite Low}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: cold.png|Quite Low}}
 
|-
 
|-
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[ischemia]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[ischemia]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 1
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 1
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 5
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 5.00
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: cold.png|Very Low}} {{#icon: cold.png|Very Low}} {{#icon: cold.png|Very Low}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: cold.png|Very Low}} {{#icon: cold.png|Very Low}} {{#icon: cold.png|Very Low}}
 
|-
 
|-
Line 143: Line 143:
 
|}
 
|}
 
|
 
|
|
+
| style="vertical-align: top"|
 
{| cellspacing=1 cellpadding=5 align=center
 
{| cellspacing=1 cellpadding=5 align=center
 
|-
 
|-
Line 153: Line 153:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Angina]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Angina]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 45
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 45
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 100
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 100.00
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
|-
 
|-
Line 163: Line 163:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Myocardial Infarction]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Myocardial Infarction]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 52
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 52
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 91
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 91.00
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|High}} {{#icon: chilli.png|High}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|High}} {{#icon: chilli.png|High}}
 
|-
 
|-
Line 173: Line 173:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Coronary Artery Disease]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Coronary Artery Disease]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 1
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 1
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 87.2
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 87.20
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|High}} {{#icon: chilli.png|High}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|High}} {{#icon: chilli.png|High}}
 
|-
 
|-
Line 198: Line 198:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Syndrome]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Syndrome]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 1
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 1
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 50
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 50.00
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: cold.png|Quite Low}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: cold.png|Quite Low}}
 
|-
 
|-
Line 220: Line 220:
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of <span style="background-color:#FFDEAD">chest</span> pain were the ECG and myoglobin and between 4-12 h after onset of chest pain the ECG, <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> and <span style="background-color:#FFFF00">myoglobin</span>.
+
| Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of <span style="background-color:#FFA07A">chest pain</span> were the ECG and myoglobin and between 4-12 h after onset of <span style="background-color:#FFA07A">chest pain</span> the ECG, <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> and <span style="background-color:#FFFF00">myoglobin</span>.
  
 
|-
 
|-
Line 226: Line 226:
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span>
+
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span> associated with <span style="color:#FF0000">'''angina'''</span>
 
|-
 
|-
 
|}
 
|}
Line 245: Line 245:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.57
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.49
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of <span style="background-color:#FFDEAD">chest</span> pain were the ECG and <span style="background-color:#FFFF00">myoglobin</span> and between 4-12 h after onset of chest pain the ECG, <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> and myoglobin.
+
| Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of <span style="background-color:#FFA07A">chest pain</span> were the ECG and <span style="background-color:#FFFF00">myoglobin</span> and between 4-12 h after onset of <span style="background-color:#FFA07A">chest pain</span> the ECG, <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> and myoglobin.
  
 
|-
 
|-
Line 258: Line 258:
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span>
+
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span> associated with <span style="color:#FF0000">'''angina'''</span>
 
|-
 
|-
 
|}
 
|}
Line 277: Line 277:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.58
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.50
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of <span style="background-color:#FFDEAD">chest</span> pain were the ECG and myoglobin and between 4-12 h after onset of chest pain the ECG, <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> and <span style="background-color:#FFFF00">myoglobin</span>.
+
| Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of <span style="background-color:#FFA07A">chest pain</span> were the ECG and myoglobin and between 4-12 h after onset of <span style="background-color:#FFA07A">chest pain</span> the ECG, <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> and <span style="background-color:#FFFF00">myoglobin</span>.
  
 
|-
 
|-
Line 290: Line 290:
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span>
+
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span> associated with <span style="color:#FF0000">'''angina'''</span>
 
|-
 
|-
 
|}
 
|}
Line 309: Line 309:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.57
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.49
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of <span style="background-color:#FFDEAD">chest</span> pain were the ECG and <span style="background-color:#FFFF00">myoglobin</span> and between 4-12 h after onset of chest pain the ECG, <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> and myoglobin.
+
| Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of <span style="background-color:#FFA07A">chest pain</span> were the ECG and <span style="background-color:#FFFF00">myoglobin</span> and between 4-12 h after onset of <span style="background-color:#FFA07A">chest pain</span> the ECG, <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> and myoglobin.
  
 
|-
 
|-
Line 322: Line 322:
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span>
+
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span> associated with <span style="color:#FF0000">'''angina'''</span>
 
|-
 
|-
 
|}
 
|}
Line 341: Line 341:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.58
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.50
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| In patients admitted 4-12 h after onset of <span style="background-color:#FFDEAD">chest</span> pain, the likelihood ratios for abnormal and normal <span style="background-color:#FFFF00">myoglobin</span> concentrations were 4.88 and 0.42; for troponin T 3.11 and 0.31; for CK activity 3.44 and 0.49 and for <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> 4.08 and 0.54 respectively.  
+
| In patients admitted 4-12 h after onset of <span style="background-color:#FFA07A">chest pain</span>, the likelihood ratios for abnormal and normal <span style="background-color:#FFFF00">myoglobin</span> concentrations were 4.88 and 0.42; for troponin T 3.11 and 0.31; for CK activity 3.44 and 0.49 and for <span style="background-color:#FFFF00">CK-MB</span> <span style="background-color:#B0E0E6">activity</span> 4.08 and 0.54 respectively.  
 
|-
 
|-
 
|
 
|
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span>
+
| <span style="color:#800000">'''CK-MB'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span> associated with <span style="color:#FF0000">'''angina'''</span>
 
|-
 
|-
 
|}
 
|}
Line 372: Line 372:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.50
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.50
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| In patients admitted 4-12 h after onset of <span style="background-color:#FFDEAD">chest</span> pain, the likelihood ratios for abnormal and normal <span style="background-color:#FFFF00">myoglobin</span> concentrations were 4.88 and 0.42; for troponin T 3.11 and 0.31; for <span style="background-color:#FFFF00">CK</span> <span style="background-color:#B0E0E6">activity</span> 3.44 and 0.49 and for CK-MB activity 4.08 and 0.54 respectively.  
+
| In patients admitted 4-12 h after onset of <span style="background-color:#FFA07A">chest pain</span>, the likelihood ratios for abnormal and normal <span style="background-color:#FFFF00">myoglobin</span> concentrations were 4.88 and 0.42; for troponin T 3.11 and 0.31; for <span style="background-color:#FFFF00">CK</span> <span style="background-color:#B0E0E6">activity</span> 3.44 and 0.49 and for CK-MB activity 4.08 and 0.54 respectively.  
 
|-
 
|-
 
|
 
|
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''CK'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span>
+
| <span style="color:#800000">'''CK'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">activity</span>) of <span style="color:#800000">'''myoglobin'''</span> in <span style="color:#808000">chest</span> associated with <span style="color:#FF0000">'''angina'''</span>
 
|-
 
|-
 
|}
 
|}
Line 403: Line 403:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=8174583 8174583]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.50
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.49
 
|}
 
|}
 
|-
 
|-
Line 434: Line 434:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=7980735 7980735]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=7980735 7980735]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.25
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.09
 
|}
 
|}
 
|-
 
|-
Line 465: Line 465:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=9034351 9034351]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=9034351 9034351]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 1.05
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.33
 
|}
 
|}
 
|-
 
|-
Line 496: Line 496:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=9034351 9034351]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=9034351 9034351]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 1.05
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.33
 
|}
 
|}
 
|-
 
|-
Line 527: Line 527:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=9034351 9034351]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=9034351 9034351]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 1.05
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.33
 
|}
 
|}
 
|-
 
|-
Line 558: Line 558:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=9034351 9034351]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=9034351 9034351]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 1.05
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.33
 
|}
 
|}
 
|-
 
|-
Line 589: Line 589:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=11889791 11889791]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=11889791 11889791]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.74
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.48
 
|}
 
|}
 
|-
 
|-
Line 620: Line 620:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=10608583 10608583]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=10608583 10608583]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.09
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0
 
|}
 
|}
 
|-
 
|-

Latest revision as of 12:30, 14 September 2012

Context Info
Confidence 0.07
First Reported 1993
Last Reported 2002
Negated 0
Speculated 0
Reported most in Abstract
Documents 13
Total Number 13
Disease Relevance 8.54
Pain Relevance 4.87

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (Mb)
Anatomy Mention Frequency
chest 6
urine 1
ck (Drosophila melanogaster)
Mb (Rattus norvegicus)
Pain Term Frequency Confidence Heat
Angina 51 100.00 Very High Very High Very High
anesthesia 6 95.00 High High
Pain 8 86.24 High High
imagery 2 50.00 Quite Low
ischemia 1 5.00 Very Low Very Low Very Low
Disease Term Frequency Confidence Heat
Angina 45 100.00 Very High Very High Very High
Cv General 3 Under Development 6 93.04 High High
Myocardial Infarction 52 91.00 High High
Diuresis 1 89.28 High High
Coronary Artery Disease 1 87.20 High High
Pain 8 86.24 High High
Emergencies 5 84.52 Quite High
Muscular Dystrophy 7 78.52 Quite High
Rhabdomyolysis 4 76.08 Quite High
Syndrome 1 50.00 Quite Low

[edit] Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of chest pain were the ECG and myoglobin and between 4-12 h after onset of chest pain the ECG, CK-MB activity and myoglobin.
CK-MB Binding (activity) of myoglobin in chest associated with angina
1) Confidence 0.07 Published 1994 Journal Eur. Heart J. Section Abstract Doc Link 8174583 Disease Relevance 0.57 Pain Relevance 0.49
Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of chest pain were the ECG and myoglobin and between 4-12 h after onset of chest pain the ECG, CK-MB activity and myoglobin.
CK-MB Binding (activity) of myoglobin in chest associated with angina
2) Confidence 0.07 Published 1994 Journal Eur. Heart J. Section Abstract Doc Link 8174583 Disease Relevance 0.58 Pain Relevance 0.50
Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of chest pain were the ECG and myoglobin and between 4-12 h after onset of chest pain the ECG, CK-MB activity and myoglobin.
CK-MB Binding (activity) of myoglobin in chest associated with angina
3) Confidence 0.07 Published 1994 Journal Eur. Heart J. Section Abstract Doc Link 8174583 Disease Relevance 0.57 Pain Relevance 0.49
Stepwise logistic regression analysis showed that the best predictors of AMI within 4 h after onset of chest pain were the ECG and myoglobin and between 4-12 h after onset of chest pain the ECG, CK-MB activity and myoglobin.
CK-MB Binding (activity) of myoglobin in chest associated with angina
4) Confidence 0.07 Published 1994 Journal Eur. Heart J. Section Abstract Doc Link 8174583 Disease Relevance 0.58 Pain Relevance 0.50
In patients admitted 4-12 h after onset of chest pain, the likelihood ratios for abnormal and normal myoglobin concentrations were 4.88 and 0.42; for troponin T 3.11 and 0.31; for CK activity 3.44 and 0.49 and for CK-MB activity 4.08 and 0.54 respectively.
CK-MB Binding (activity) of myoglobin in chest associated with angina
5) Confidence 0.07 Published 1994 Journal Eur. Heart J. Section Abstract Doc Link 8174583 Disease Relevance 0.50 Pain Relevance 0.50
In patients admitted 4-12 h after onset of chest pain, the likelihood ratios for abnormal and normal myoglobin concentrations were 4.88 and 0.42; for troponin T 3.11 and 0.31; for CK activity 3.44 and 0.49 and for CK-MB activity 4.08 and 0.54 respectively.
CK Binding (activity) of myoglobin in chest associated with angina
6) Confidence 0.06 Published 1994 Journal Eur. Heart J. Section Abstract Doc Link 8174583 Disease Relevance 0.50 Pain Relevance 0.49
Myoglobin concentration, in the coronary care population studied, proved to be as specific as CK-MB concentration (92.6% in both cases) but with sensitivity of 100% being achieved 1.5 h post admission rather than 4 h post admission in the case of CK-MB.
CK-MB Binding (concentration) of Myoglobin
7) Confidence 0.05 Published 1993 Journal Ann. Clin. Biochem. Section Abstract Doc Link 7980735 Disease Relevance 0.25 Pain Relevance 0.09
In the time interval of 3-5 h, myoglobin, the CK-MB mass concentration and the CK-MB subform ratio were associated with the greatest areas under receiver operating characteristic (ROC) curves, but differences between these tests were small and non-significant.
CK-MB Binding (associated) of myoglobin
8) Confidence 0.02 Published 1996 Journal Scand. J. Clin. Lab. Invest. Section Abstract Doc Link 9034351 Disease Relevance 1.05 Pain Relevance 0.33
In the time interval of 3-5 h, myoglobin, the CK-MB mass concentration and the CK-MB subform ratio were associated with the greatest areas under receiver operating characteristic (ROC) curves, but differences between these tests were small and non-significant.
CK-MB Binding (associated) of myoglobin
9) Confidence 0.02 Published 1996 Journal Scand. J. Clin. Lab. Invest. Section Abstract Doc Link 9034351 Disease Relevance 1.05 Pain Relevance 0.33
In the time interval of 3-5 h, myoglobin, the CK-MB mass concentration and the CK-MB subform ratio were associated with the greatest areas under receiver operating characteristic (ROC) curves, but differences between these tests were small and non-significant.
CK-MB Binding (associated) of myoglobin
10) Confidence 0.02 Published 1996 Journal Scand. J. Clin. Lab. Invest. Section Abstract Doc Link 9034351 Disease Relevance 1.05 Pain Relevance 0.33
In the time interval of 3-5 h, myoglobin, the CK-MB mass concentration and the CK-MB subform ratio were associated with the greatest areas under receiver operating characteristic (ROC) curves, but differences between these tests were small and non-significant.
CK-MB Binding (associated) of myoglobin
11) Confidence 0.02 Published 1996 Journal Scand. J. Clin. Lab. Invest. Section Abstract Doc Link 9034351 Disease Relevance 1.05 Pain Relevance 0.33
Three hours postoperatively, dark red urine with a high concentration of myoglobin (1,390,000 ng.ml-1) was recognized with a high level of CK (63,500 IU.l-1).
CK Binding (recognized) of myoglobin in urine
12) Confidence 0.01 Published 2002 Journal Masui Section Abstract Doc Link 11889791 Disease Relevance 0.74 Pain Relevance 0.48
Venous samples were drawn at admission and 8 to 24 hours later for total creatine kinase, CK-MB fraction, troponin T, troponin I, and myoglobin.
CK-MB Binding (fraction) of myoglobin
13) Confidence 0.00 Published 1999 Journal J Nucl Cardiol Section Body Doc Link 10608583 Disease Relevance 0.09 Pain Relevance 0

[edit] General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox